Journal of Rheumatology

Article	Citations
TREX1-Associated Familial Chilblain Lupus With Cerebral Aneurysms Treated With Janus Kinase Inhibition	91
Dr. Gottlieb et al reply	64
Young-GRAPPA (Y-GRAPPA) at the 2022 GRAPPA Annual Meeting: One Year in Y-GRAPPA. Where Do We Stand, Where Do We Go?	52
The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort	49
A Move Toward Precision: Innovations in Measuring Spinal Mobility in Axial Spondyloarthritis	47
Clinical Expression of Radiographic Axial Spondyloarthritis and Its Association With HLA-B27 in European and Ibero-American Populations	46
Canadian Rheumatology Association Annual Scientific Meeting; RBC Convention Centre (and Virtually); Winnipeg, Manitoba, Canada; February 28–March 2, 2024	41
Drs. Dai and Fan reply	41
Arthritis Mutilans in Jo1 Antisynthetase Syndrome	31
Phase-Specific Healthcare Costs Associated With Giant Cell Arteritis in Ontario, Canada	31
ANTI-Β2GLYCOPROTEIN I-INDUCED NEUTROPHIL EXTRACELLULAR TRAPS CAUSE ENDOTHELIAL ACTIVATION	31
CONTEMPORARY KIDNEY OUTCOMES AMONG PATIENTS WITH LUPUS NEPHRITIS IN THE UNITED STATES	27
The State of Patient-Reported Outcome Measures in Rheumatology	27
Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting	26
Fibrous Bands: An Alternate Diagnosis to Consider for Range of Motion Limitations in Suspected Juvenile Idiopathic Arthritis	26
Factors Associated With an Electronic Health Record–Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease	26
Advancing Psoriatic Disease Knowledge: Highlights From the GRAPPA 2024 Trainee Symposium	26
Inflammation as a Treatment Target in Hand Osteoarthritis: A Review of Previous Studies and Future Perspectives	25
50th Year of Publication: Revisiting the 1980s	25
Aneurysmal Disease in Patients With Takayasu Arteritis	24
Changes in Modern Care for Juvenile Idiopathic Arthritis: How Much Does This Affect Health-Related Quality of Life?	22
Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study	22
How to Identify and Monitor Axial and Peripheral Psoriatic Arthritis by Magnetic Resonance Imaging	21
PRISTANE-INDUCED LUPUS MICE PRESENT INCREASED MEGAKARYOCYTE COUNTS ALONGSIDE OTHER HISTOPATHOLOGICAL FEATURES IN THE SPLENIC TISSUE	20
Is There Relevance of a Positive Rheumatoid Factor in Systemic Sclerosis? A Systematic Review of the Literature	20

A Reciprocal Machine Learning Approach to Defining Physiologic Compensation of the Synovial Joint in Knee Osteoarthritis	20
Description of Immune Checkpoint Inhibitor Associated Sicca-Like Syndrome from the Canadian Research Group of Rheumatology in Immuno-Oncology Database: A Case Series	20
The Discontinuation and Effectiveness of Sequential Advanced Therapy in Rheumatoid Arthritis: Real-World Data	19
Response to Treatment With Tofacitinib in 11 Patients With Refractory Granulomatosis With Polyangiitis	18
Modifiable Lifestyle Factors, Genetic Susceptibility, and Incident Radiographic Axial Spondyloarthritis	18
“Gallia est omnis divisa in partes tres”: Social Media Platforms as a New Educational Channel for Pediatric Rheumatology	18
DYSREGULATION OF THE EXPRESSION OF HUMAN RETROVIRUSES IN SYSTEMIC LUPUS ERYTHEMATOSUS	18
Ultrasound in the Management of Patients With Psoriatic Arthritis: Systematic Literature Review and Novel Algorithms for Pragmatic Use	18
Follow-up Contrast-Enhanced Ultrasonography of the Carotid Artery in Patients With Takayasu Arteritis: A Retrospective Study	18
Transforming Psoriatic Disease Care Through Innovation and Real-World Data: GRAPPA 2025 Soapbox Highlights	18
THE USE OF POLYSIMPTOMATIC DISTRESS SCALE IN A MULTICENTRIC COHORT OF SLE PATIENTS TO IDENTIFY PATIENTS WITH HIGH LEVELS TYPE 2 SYMPTOMS	17
EFAVALEUKIN ALFA IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A BAYESIAN ADAPTIVE, PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED DOSE-RANGING STUDY	16
AN UNUSUAL CASE OF LYMPHOCYTIC ENTEROCOLITIS AND VASCULITIS AS THE INITIAL MANIFESTATION OF SLE	16
DELAYED ONSET OF MALE INFERTILITY AFTER TREATMENT WITH HIGH DOSE OF CYCLOPHOSPHAMIDE FOR LUPUS NEPHRITIS	16
CD38 IS OVEREXPRESSED BY IMMUNE CELLS IN CUTANEOUS LUPUS SKIN	16
THE IMPORTANCE OF TRANS-ESOPHAGEAL ECHOCARDIOGRAPHY IN DIAGNOSING LIBMAN-SACKS ENDOCARDITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT	16
EFFECT OF CENERIMOD, AN S1P1 MODULATOR, ON FATIGUE IN SLE: RESULTS FROM THE PHASE 2 CARE STUDY	16
OUTCOMES OF ADULTS WITH CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOUS: A SCOPING REVIEW	16
Association Between HLA Alleles and Autoantibodies in Dermatomyositis Defined by Sarcoplasmic Expression of Myxovirus Resistance Protein A	15
Beyond Pain Intensity: The Relationship Between Pain Catastrophizing and Quality of Life in Psoriatic Arthritis	14
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study	14
Challenges of Assessment of SpondyloArthritis international Society Criteria in Real-World Colombian Patients With Spondyloarthritis: A Cross-Sectional Study	14
Scrotal Calcinosis in Juvenile Systemic Sclerosis	14
Missing the Mark? American College of Rheumatology 2019 Guidelines for Intraarticular Hyaluronic Acid Injection and Osteoarthritis Knee Pain	14
Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist	14
Evaluation of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation	13
Long-Term Outcomes in Lung Transplant for Anti-Melanoma Differentiation-Associated Gene 5 Antibody Positive Interstitial Lung Disease: A Case Series	13
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review	13
More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus	13
SIMILARITY AND DIVERSITY IMMUNOLOGICAL ABERRATIONS IN STABLE BENIGN IMMUNITY AND TOWARD ANA-RELATED AUTOIMMUNE DISEASES IN ANA-POSITIVE AT-RISK POPULATIONS	13
Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis: Association With Immune Activation	13
Drs. Chung and McMahan reply	13
ADMINISTRATION OF BELIMUMAB IN EARLY ACTIVE LUPUS PATIENTS HINDERS ACCRUAL OF EULAR/ACR CRITERIA WITHIN THE FIRST 12 MONTHS OF TREATMENT	13
Examination of HLA-DRB1*15-linked Candidate Antigens in Still Disease With and Without Lung Disease and Drug-Associated Immune Reactions	13
Do Monosodium Urate Crystals Reduce at Different Rates in Joints and Tendons During Urate-Lowering Therapy? A Dual-Energy Computed Tomography Study	12
Examining the Role of Wearables in Inflammatory Arthritis Care: A Narrative Literature Review	12
Epidemiological Characteristics of Psoriatic Disease in Peru from 2016 to 2023	12
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM)	12
The Effects of Continuity of Rheumatology Care on Emergency Department Utilization and Hospitalizations for Individuals With Early Rheumatoid Arthritis: A Population-Based Study	12
Tocilizumab in Behçet Disease: A Multicenter Study of 30 Patients	12
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus	12
Normalizing Uricemia in Psoriatic Arthritis: A Hypothetical Reduction of Atherosclerotic Plaque Burden	11
ASSOCIATION BETWEEN IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE OUTCOMES AND DISEASE ACTIVITY IN SLE: A REAL-WORLD COHORT STUDY	11
VALIDATION OF A SCORE FOR THE PREDICTION OF SERIOUS INFECTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM A LATIN AMERICAN LUPUS COHORT	11
FACTORS INFLUENCING SUBJECTIVE MENTAL ALTERATIONS: UNRAVELING THE LUPUS BRAIN FOG	11
Pediatric Sarcoidosis: Retrospective Analysis of Biopsy-Proven Patients	11
COVID-19 BOOSTER VACCINATION, EITHER MRNA OR PROTEIN SUBUNIT VACCINES, APPEARS SAFE IN RITUXIMAB-TREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND VASCULITIS	11
SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF INDUCTION TREATMENTS FOR LUPUS NEPHRITIS	11
DRUG LEVELS AND ANTI-DRUG ANTIBODIES OVER 2 YEARS OF BELIMUMAB THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS	11
GENETICS OF EGFR VARIABILITY AS A PROXY FOR LUPUS NEPHRITIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS	11

INCREASE OF IL10 AND INFA2 ARE ASSOCIATED TO CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS	11
VARIATIONS IN TACROLIMUS WHOLE BLOOD CONCENTRATIONS DURING PREGNANCY AND ITS IMPLICATIONS FOR THERAPEUTIC DRUG MONITORING: A SYSTEMATIC REVIEW AND META-ANALYSIS	11
DOES SLEDAI-2K REFLECT THE INTERFERON-ALPHA GENE SIGNATURE IN SYSTEMIC LUPUS ERYTHEMATOSUS? PRELIMINARY RESULTS FROM A COHORT	10
SERUM NEUROFILAMENT LIGHT TO DISTINGUISH AND MONITOR ACTIVITY IN A COHORT OF NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	10
Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib	10
Real-World Coverage With Influenza, Pneumococcal, and Herpes Zoster Vaccines Among Patients With Rheumatic Diseases in a Nationwide Healthcare Plan	10
RANDOMIZED, PLACEBO-CONTROLLED PHASE II STUDY OF ENPATORAN, A SMALL MOLECULE TOLL-LIKE RECEPTOR 7/8 INHIBITOR, IN CUTANEOUS LUPUS ERYTHEMATOSUS: RESULTS FROM COHORT A	10
CHARACTERISTICS OF NEUROLOGICAL MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS AT A TERTIARY UNIVERSITY HOSPITAL	10
THE TYPE I IFN SIGNATURE BETWEEN PATIENTS WITH RA AND SLE.	10
A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy–Associated Interstitial Lung Disease	10
Outcomes in Systemic Sclerosis–Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III Antibodies	10
ASSESSMENT OF FATIGUE IN A MONOCENTRIC ITALIAN COHORT OF PATIENTS AFFECTED BY SLE AND OTHER RHEUMATIC DISEASES (RDS) THROUGH VALIDATED QUESTIONNAIRES	10
ALL SUBCOMPONENTS OF THE CUTANEOUS LUPUS ERYTHEMATOSUS DISEASE AREA AND SEVERITY INDEX-ACTIVITY (CLASI-A) ARE RELEVANT TO IDENTIFY AND DETECT CHANGES IN SKIN ACTIVITY	10
IMAGING INSIGHTS INTO JC VIRUS-ASSOCIATED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN NEUROPSYCHIATRIC LUPUS: A CASE REPORT	10
The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculi	10
Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus	10
Functional Connectivity and Structural Signatures of the Visual Cortical System in Fibromyalgia: A Magnetic Resonance Imaging Study	9
The Uses and Advances in Imaging for Psoriatic Arthritis: A Scoping Review	9
The Efficacy of Leflunomide in the Treatment of Giant Cell Arteritis: A Systematic Review and Meta-Analysis	9
Modulating the Gut-Joint Axis: The Impact of Anti-TNF Therapy on Gut Microbiota in Ankylosing Spondylitis - A Systematic Review	9
Text-Based Messaging to Support Rheumatoid Arthritis Care: An Analysis of the Frequency and Content of Text Messages	9
Atlantoaxial Subluxation in Patients with Psoriatic Arthritis	9
Hot Topics: Exploring Artificial Intelligence and Inflammatory Memory in the Management of Psoriatic Diseases	9
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review	9
Current Barriers to Accessing Mental Healthcare Resources for Inflammatory Arthritis Patients and How to Improve Support	9
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment	9
Exploring Causal Relationships of Depression and Psoriatic Disease (Psoriatic Arthritis and Psoriasis) Through Mendelian Randomization	9
The Ecological Relationship Between Food Access and Disease Activity in Canadian Children newly diagnosed with Juvenile Idiopathic Arthritis	9
How Does Juvenile Idiopathic Arthritis Affect the Employment and Usual Activities of Adolescents? The UCAN CAN-DU and CURE International Prospective Study	9
Negative Health Impacts of Navigating the Healthcare System for Musculoskeletal Conditions: Healthcare User Perspectives	9
TRACER: Transition to Adulthood Through Coaching and Empowerment in Rheumatology, a Feasibility Study	9
Development of MOGAD in a Patient with Granulomatosis with Polyangiitis and Giant Cell Arteritis Overlap Syndrome	9
GRAPPA 2024 Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees	8
Knowledge About Human Papillomavirus Among Patients With Immune-Mediated Inflammatory Diseases	8
Pursuing Gender Equity in Rheumatology: Thinking Beyond Gender Representation to Assess Gender Equality	8
Impaired Neutrophil Extracellular Trap (NET) Degradation in Rheumatoid Arthritis (RA) and Preclinical RA Is Mediated by Anti-NET Antibodies	8
An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome	8
IMIQUIMOD-INDUCED ONSET OF DISEASE IN LUPUS-PRONE NZB/W F1 MICE	8
Sjögren Disease: Does an Accurate Diagnosis Matter?	8
Unveiling Deficiency of Adenosine Deaminase 2: An Adult Patient With Recurrent Strokes, Vasculitic Ulcers, and Bowel Perforation	8
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study	8
IMPACT OF BELIMUMAB ON EFFICACY, SAFETY AND IMMUNE PHENOTYPES IN REFRACTORY AND ACTIVE LUPUS NEPHRITIS IN REAL-WORLD LOOPS REGISTRY	8
Dr. Joerns et al reply	8
Understanding the Resolution of Clinically Suspect Arthralgia: Moving Forward, but Challenges Remain	8
An Overview of Reviews to Inform Organization-Level Interventions to Address Burnout in Rheumatologists	8
Formulating Knee Osteoarthritis Management Plans Taking Type 2 Diabetes Into Account: Qualitative Study of Arthritis Therapists Using Theoretical Domains Framework	8
Association Between Depressive Symptoms and Self-Reported Physical Activity in Persons With Knee Osteoarthritis	8
An Evaluation of Burnout Among US Rheumatology Fellows: A National Survey	8
High Frequency of Foot Insufficiency Fractures in Patients With Rheumatic Diseases Referred for Magnetic Resonance Imaging: What Is the Clinical Relevance?	8
GRAPPA 2024: Innovations in Education Workshop	8
Epidemiological Characteristics of Patients With Juvenile Dermatomyositis in China: A Multicenter Study	8
Utilization of Rehabilitation Services After Idiopathic Inflammatory Myopathy Diagnosis: A Retrospective Cohort Assessment in the United States	8
Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series	8
Advances in Psoriatic Disease Research: Insights From GRAPPA Pilot Research Awardees	8
Modified Juvenile Spondyloarthritis Disease Activity Index in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry	8
The Opportunities and Challenges of Telemedicine in the Management of People With Rheumatoid Arthritis	8
Unrecognized Pneumatosis Intestinalis in Antimelanoma Differentiation-Associated Gene 5 Antibody–Associated Dermatomyositis	8
Predictive Value of Severe Symptoms for Residual Disease After Transitioning From High to Low Disease Activity in Axial Spondyloarthritis: A Longitudinal Study	8
Determinants of Cervical Cancer Screening Patterns Among Women With Systemic Lupus Erythematosus	7
Comparing Large Vessel Uptake of 68Ga-HA-DOTATATE to 18F-FDG Using PET/CT Imaging in Patients with Active Giant Cell Arteritis	7
A Clinical Audit of Vaccination in Patients Living with Inflammatory Arthritis and Receiving Specialty Medications	7
Association of the Apollo Wearable With Fatigue, Raynaud Phenomenon, and Quality of Life in Patients With Systemic Sclerosis: A Pilot Study	7
The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases	7
Patient Perspectives and Experiences With Medication for Gout: A Thematic Synthesis of Qualitative Studies	7
Patient-Provider Communication in Pediatric Rheumatology: A Narrative Review and Presentation of Pilot Data	7
Are Patients With Systemic Sclerosis Subject to an Increased Risk of Developing Superficial Erosion of Atherosclerotic Plaques?	7
EFFICACY AND SAFETY OF ELSUBRUTINIB AND UPADACITINIB COMBINATION AND UPADACITINIB MONOTHERAPY FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS THROUGH 104 WEEKS	7
EXPEDITING LUPUS CLASSIFICATION OF AT-RISK INDIVIDUALS USING NOVEL TECHNOLOGY: OUTCOMES OF A PILOT STUDY	7
CARDIAC LUPUS: A DISEASE NOT TO BE NEGLECTED.	7
Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study	7
Low Uveitis Rates in Patients with Axial Spondyloarthritis or Psoriatic Arthritis Treated with Bimekizumab: Long-Term Results from Phase 2B/3 Trials	7
TYPE 2 LUPUS IS THE MAJOR PREDICTOR OF FATIGUE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CROSS-SECTIONAL STUDY OF 200 PATIENTS	7
BRIDGING THE GAP: IDENTIFYING AND ADDRESSING BARRIERS TO CARE FOR PATIENTS WITH LUPUS AND LUPUS NEPHRITIS	7
Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study	7
The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue Disease	7
How Representative Are Data From Clinical Trials in Axial Spondyloarthritis for Women?	7
A Frameshift Mutation ofNLRP12in a Patient With Chronic Recurrent Multifocal Osteomyelitis	7
Eosinophilic Granulomatosis With Polyangiitis With a Pathologically Proven Calcified Lung Nodule	7
DOWNREGULATION OF YTHDF2 IN THE SPINAL DORSAL HORN CONTRIBUTES TO THE GENESIS OF CHRONIC PAIN INDUCED BY SYSTEMIC LUPUS ERYTHEMATOSUS	7
VOLUME AND DYNAMIC BLOOD FLOW OF THE CHOROID PLEXUS IN NEUROINFLAMMATORY DISEASE	7

Cumulative Incidence of Cancer Screening for Breast, Cervical, Prostate, and Colorectal Cancer in Patients With Rheumatoid Arthritis	7
Elevated Serum Brain Injury Markers Correlate with Disease Features and Interferons in Children with Systemic Lupus Erythematosus	7
The Prognostic Potential of End-Stage Knee Osteoarthritis and Its Components to Predict Knee Replacement: Data From the Osteoarthritis Initiative	7
Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual Meeting	7
TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS	7
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM)	7
Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events	7
Infections in Vasculitis: Can We Create an Epidemic of Change?	7
ADVANCES IN TARGETED THERAPIES AND IMMUNOMODULATORY STRATEGIES IN LUPUS	7
MACROPHAGE ACTIVATION SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS: REPORT OF 8 CASES	7
REAL-WORLD EXPERIENCE OF EFFECTIVENESS OF NONMEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR RITUXIMAB AND BETWEEN BIOSIMILARS IN CONNECTIVE TISSUE DISEASES AND VASCULITIS	6
Tight Control and Radiological Progression: The Radiographic Outcomes of the TICOPA Study	6
Effects of Biologics on Temporomandibular Joint Inflammation in Juvenile Idiopathic Arthritis	6
Janus Kinase Inhibitor Exposure During Pregnancy in Immune-Mediated Inflammatory Diseases: A Case Series of 3 Patients	6
Reflections Across 2 Continents: A Journey Between Canada and the United Arab Emirates	6
CelebratingThe Journal of Rheumatology’s 50th Year of Publication	6
Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study	6
Optimizing Care for Pregnancy in Rheumatic Diseases: Barriers and Potential Solutions	6
MPO-ANCA Positivity in a Patient with Pyoderma Gangrenosum and Graves’ Disease: A Case Report and Review of the Literature	6
Getting the Diagnosis Right: What’s in a Name?	6
Comparative Analysis of Damage Accrual in Lupus Nephritis Stratified by Biological Sex	6
Bridging Generations: Leveraging Technology and Artificial Intelligence for Better Research, Outreach, and Daily Practice	6
Metabolic Stress Remodeling: Insights into the Role(s) of FOXO1 in Promoting Cancer-Like Changes in Systemic Sclerosis (SSc)	6
EFFECT OF COMORBIDITY AND STANDARD THERAPY ON INTERFERON STATUS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS	6
Development of National Clinical Practice Guidelines for Transition in Rheumatology	6
Dose-Response Relationship Between Alcohol Consumption and Gout Risk: Do Subtypes of Alcoholic Beverages Make a Difference?	6
PROPOSALS FOR DEFINITIONS OF MODERATE AND SEVERE DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS. IMPACT ON FLARES, QUALITY OF LIFE, DAMAGE ACCRUAL, HOSPITALIZATIONS AND MORTALITY	6
A Retrospective Analysis of Outcome in Melanoma Differentiation–Associated Gene 5–Related Interstitial Lung Disease Treated with Tofacitinib or Tacrolimus	6
The Forgotten Costs of SLE: Estimating Indirect Costs in a National SLE Cohort	6
Golimumab for Adherence in Rheumatoid Arthritis (GO FAR): A Multicenter, Prospective, Observational Study of Patients Treated with Golimumab for Rheumatoid Arthritis	6
Concurrent IgG4-Related Disease and Giant Cell Arteritis: A Rare Case Study	6
Immune Checkpoint Inhibitors: A Pediatric Needs Assessment	6
Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody–Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk	6
Safety and Healthcare Use Following COVID-19 Vaccination Among Adults With Rheumatoid Arthritis: A Population-Based Self-Controlled Case Series Analysis	6
EFFICACY AND SAFETY OF TACROLIMUS IN THE MAINTENANCE TREATMENT OF PATIENTS WITH LUPUS NEPHRITIS	6
Eosinophilic Granulomatosis With Polyangiitis With a Pathologically Proven Calcified Lung Nodule	6
Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response	6
Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024	6
Co-Designing a Patient-Facing Dashboard with Patients and Healthcare Providers: Gathering User Input	6
Cigarette Smoking Increases the Prevalence of Hip Joint Involvement in Ankylosing Spondylitis: A Real-World Case-Control Study	6
A SURVEY OF PATIENTS WITH SLE SUGGESTS LIMITED KNOWLEDGE OF NEPHRITIS UNLESS THERE IS ALREADY CHRONIC KIDNEY DISEASE	6
DAPIROLIZUMAB PEGOL DEMONSTRATED IMPROVEMENT IN QUALITY OF LIFE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: LUPUSQOL RESULTS FROM A PHASE 3 TRIAL	6
The Use of Real-World Data for Studies of Dynamic Disease Processes	6
ANIFROLUMAB EFFECTS ON RESPONSE TO INFLUENZA VACCINE IN SLE	6
Long-Term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis in Japan: 10-Year Analysis of the Real-World TRUST Study	6
Arthritis Mutilans in Psoriatic Arthritis: The Consequences of Delayed Treatment	6
Analyzing Gender Disparities in Ankylosing Spondylitis: Exploring the Factors Behind Severe Sacroiliac Joint Disease Without Spinal Involvement	6
Women With Psoriatic Arthritis Experience Higher Disease Burden Than Men: Findings From a Real-World Survey in the United States and Europe	6
Autoinflammatory Diseases and Vasculitis: The Missing Link	6
DMARD Utilization Patterns in Community-Dwelling Rheumatoid Arthritis Patients: Insights from Linked Primary Care and Pharmaceutical Data	6
Imaging in Psoriatic Arthritis: Focus on Axial Magnetic Resonance Imaging and Peripheral Musculoskeletal Ultrasound	6
Safety and Tolerability of a Combination of Curcumin, Omega-3 and Vitamin D: Results from the PASCOD Study, an RA Prevention Protocol	6
Sarcopenia as a Feature of Musculoskeletal Manifestations of Pediatric Crohn’s Disease	6
DisseminatedMycobacterium haemophilumInfection Mimicking Rheumatoid Nodules	6
REDUCED FREQUENCY OF CIRCULATING INTERLEUKIN-16 EXPRESSING CD4+AND CD8+T CELLS ASSOCIATE WITH INCREASED URINARY IL16 LEVELS AND PROMOTE TH1 AND CD8+T CELL MIGRATION IN LUPUS PATIENTS	5
Bimekizumab Maintained Stringent Clinical Responses Over 2 Years in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies	5
DEVELOPMENT OF A QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODEL FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) FOR THERAPEUTIC EVALUATION IN A VIRTUAL POPULATION	5
Sociocultural and Economic Disparities in Physical Therapy Utilization Among Insured Older Adults With Rheumatoid Arthritis	5
Assessing Competencies, Needs, and Satisfaction With the Transition From Pediatric to Adult Health Care in Rheumatology: Development and Validation of the Transition-KompAZ	5
The Incidence of Herpes Zoster Is Increased in the Population of Patients With Rheumatoid Arthritis	5
50th Year of Publication: Revisiting the 1980s	5
ANALYSIS OF PULMONARY COMPLICATIONS IN SLE PATIENTS WITH AND WITHOUT COVID-19: A NATIONAL INPATIENT STUDY	5
Degenerative Disc Disease in Young Adults With Psoriatic Arthritis	5
REAL-WORLD ASSESSMENT OF PATTERNS OF PAIN TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: A PATHWAY VISUALIZATION STUDY USING EHR	5
DISTINCT MOLECULAR PROFILES OF REMISSION POST-CD19 CAR-T CELL THERAPY VERSUS STANDARD IMMUNOSUPPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS	5
ANTI-C1Q ANTIBODIES AS INDICATORS OF DISEASE ACTIVITY, RENAL INVOLVEMENT, AND NON-SCARRING ALOPECIA IN PATIENTS WITH SLE	5
PROTEOMIC ANALYSIS OF SERUM OVER TIME TO FORECAST TREATMENT RESPONSE IN LUPUS NEPHRITIS	5
NONINVASIVE HIGH-THROUGHPUT SERUM PROTEOMICS FOR DISTINGUISHING SUBTYPES OF LUPUS NEPHRITIS	5
The Road to a New Horizon in Psoriatic Arthritis	5
Elucidating the Program Theory of a Successful Interdisciplinary Team-Based Model of Rheumatology Care: An Implementation Science Exploratory Case Study	5
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies	5
Validation of Different Dementia Code-Based Definitions in a Population-Based Study of Rheumatoid Arthritis	5
Calcium Pyrophosphate Crystals in a Child With Wilson Disease: An Ominous Sign or Incidental Finding?	5
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue With Spontaneous Shrinkage in a Patient With Sjögren Syndrome	5
Survival After Lung Transplantation in Patients With Rheumatoid Arthritis–Associated Lung Disease	5
A EULAR/ACR (2019) SLE CLASSIFICATION CRITERIA SCORE ≥20 IS A MARKER OF SEVERE DISEASE IN A PREVALENT SLE COHORT FROM THE PORTUGUESE REUMA.PT REGISTRY	5
Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region	5
RESPONSE TO HYDROXYCHLOROQUINE IN IMMUNE THROMBOCYTOPENIA IN CHILDHOOD-ONSET SLE	5
Correlation of Fibromyalgia Survey Questionnaire and Quantitative Sensory Testing Among Patients With Active Rheumatoid Arthritis	5
AUTOIMMUNE DISEASE PREVALENCE IN PEOPLE LIVING WITH HIV AT CIPTO MANGUNKUSUMO GENERAL HOSPITAL: A COHORT STUDY	5
Update to a Systematic Review on Quality Measures for Rheumatoid Arthritis	5
PARTNERING WITH ADOLESCENTS AND YOUNG ADULTS WITH CHILDHOOD-ONSET LUPUS TO IMPROVE ENGAGEMENT IN CARE	5
Rapid Review of Transition Outcomes in Youth with Rheumatic Diseases	5
50 Years ofThe Journal of Rheumatology	5
Seronegative Sjögren Syndrome: A Forgotten Entity?	5
Burden of Comorbidities Predicts 30-Day Rehospitalizations in Young Adult Medicare Beneficiaries With Systemic Lupus Erythematosus	5
Effective Treatment of Janus Kinase 1/3 Inhibitor in Blau Syndrome From a Multicenter Retrospective Study in Central China	5
Acute Severe Inflammatory Lumbar Spinal Pain Induced by Calcium Pyrophosphate Crystals: Computed Tomography Is Everything	5
EXPLORING PHYSICAL ACTIVITY ENGAGEMENT AND SUPPORT IN INDIVIDUALS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE IMPACT OF SOCIAL SUPPORT, HEALTHCARE PROVIDER RELATIONSHIPS, AND BUILT ENVIRONMENTS	5
NOVEL 3-BASE OLIGONUCLEOTIDE THERAPEUTIC SOF-SKN™ ANTAGONISES TLR7/8 IN AUTOIMMUNE SKIN DISEASE	5
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH SLE ACROSS 5 REGISTRIES – THE LUPUSNET FEDERATED DATA NETWORK	5
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group	5
The Significance of Intracellular Versus Extracellular Calcium Pyrophosphate Crystals in Diagnosing Calcium Pyrophosphate Crystal Arthritis	5
CLINICAL IMPACT OF C-CAR168, A NOVEL ANTI-CD20/BCMA COMPOSITE AUTOLOGOUS CAR T THERAPY, IN REFRACTORY LUPUS NEPHRITIS	5
Patient Perspectives of the Manifestations and Treatment of Anti-MDA5 Antibody–Positive Dermatomyositis: An Observational Survey	5